Treatment under development:Toward expanding the indication to include knee osteoarthritis

J-TEC is conducting clinical trials with the aim of expanding the indication for Autologous Cultured Cartilage so that it can also be provided to patients with secondary knee osteoarthritis caused by trauma, etc. In the clinical trials, Autologous Cultured Cartilage made by culturing healthy cartilage cells from the target patients is transplanted into the affected parts of their knees and a study is conducted to confirm the efficacy and safety of this treatment.

The use and commercialization of the medicinal products developed by Japan Tissue Engineering Co., Ltd. that are referred to on this website are approved only in Japan. A potential use and commercialization in other regions will be subject to the prior granting of a marketing authorization in the given territory and compliance with applicable laws.